Piper Sandler analyst Casey Orr Whitman reinstates FVCBankcorp (NASDAQ:FVCB) with a Overweight and announces $22 price target.
Coya Announces Acceptance Of Oral Presentation, “Regulatory T Cell Expansion Strategy To Target Inflammation In Alzheimer’s Disease: A Phase 1 Feasibility Study,” At The 18th International Conference On Alzheimer’s And Parkinson’s Disease In Lisbon
Alireza Faridar, MD (Houston Methodist and Weill Cornell Medical College) will present data from an open-label, proof-of-concept study in 8 AD patients treated with Low Dose IL-2 (LD IL-2) over a 4 month period that
